LU75313A1 - - Google Patents

Info

Publication number
LU75313A1
LU75313A1 LU75313A LU75313A LU75313A1 LU 75313 A1 LU75313 A1 LU 75313A1 LU 75313 A LU75313 A LU 75313A LU 75313 A LU75313 A LU 75313A LU 75313 A1 LU75313 A1 LU 75313A1
Authority
LU
Luxembourg
Application number
LU75313A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19752530405 external-priority patent/DE2530405A1/de
Priority claimed from DE19752543945 external-priority patent/DE2543945A1/de
Application filed filed Critical
Publication of LU75313A1 publication Critical patent/LU75313A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
LU75313A 1975-07-08 1976-07-06 LU75313A1 (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19752530405 DE2530405A1 (de) 1975-07-08 1975-07-08 2-benzopyranonderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE19752543945 DE2543945A1 (de) 1975-10-02 1975-10-02 2-benzopyranonderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
LU75313A1 true LU75313A1 (en:Method) 1977-02-24

Family

ID=25769120

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75313A LU75313A1 (en:Method) 1975-07-08 1976-07-06

Country Status (18)

Country Link
US (2) US4144336A (en:Method)
JP (1) JPS5225777A (en:Method)
AT (1) AT355014B (en:Method)
AU (1) AU506082B2 (en:Method)
CA (1) CA1080237A (en:Method)
CH (1) CH605889A5 (en:Method)
DK (1) DK306776A (en:Method)
ES (1) ES449629A1 (en:Method)
FI (1) FI761993A7 (en:Method)
FR (1) FR2316939A1 (en:Method)
GB (1) GB1547798A (en:Method)
IE (1) IE44012B1 (en:Method)
IL (1) IL49971A0 (en:Method)
LU (1) LU75313A1 (en:Method)
NL (1) NL7607494A (en:Method)
NZ (1) NZ181401A (en:Method)
PT (1) PT65338B (en:Method)
SE (1) SE7607856L (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU632796B2 (en) * 1989-02-23 1993-01-14 University Of North Carolina At Chapel Hill, The Etoposide analogues
US5716982A (en) * 1995-06-07 1998-02-10 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Retinoids and methods of use of same
US5703130A (en) * 1995-06-07 1997-12-30 Institute Of Materia Medica, An Institute Of The Chinese Academy Of Medical Sciences Chalcone retinoids and methods of use of same
US5968940A (en) * 1995-06-08 1999-10-19 Institute Of Materia Medica Retinoids and methods of use of same
AU1512600A (en) * 1998-12-04 2000-06-26 Takeda Chemical Industries Ltd. Process for producing cyclic amide compound
WO2007136790A2 (en) 2006-05-18 2007-11-29 Mannkind Corporation Intracellular kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1259349B (de) * 1964-10-17 1968-01-25 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Derivaten des 7-Oxycumarins
US3652557A (en) * 1968-01-19 1972-03-28 Cassella Farbwerke Mainkur Ag 3-(gamma-tertiary amino-beta-alkoxy benzoyloxy-propyl) - 4 -hydrocarbon - 5 8 - alkoxy coumarins
US3930003A (en) * 1970-07-17 1975-12-30 Troponwerke Dinklage & Co Coumarine derivatives and process for the preparation thereof
IL37284A (en) * 1970-07-17 1974-10-22 Troponwerke Dinklage & Co 3-aminoalkyl-7-ureido coumarine derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK306776A (da) 1977-01-09
US4144336A (en) 1979-03-13
FR2316939B1 (en:Method) 1979-05-18
AU1565776A (en) 1978-01-12
JPS5225777A (en) 1977-02-25
NL7607494A (nl) 1977-01-11
NZ181401A (en) 1978-03-06
FI761993A7 (en:Method) 1977-01-09
IE44012L (en) 1977-01-08
IE44012B1 (en) 1981-07-29
CA1080237A (en) 1980-06-24
ATA498876A (de) 1979-07-15
PT65338A (fr) 1976-08-01
PT65338B (fr) 1978-01-06
GB1547798A (en) 1979-06-27
FR2316939A1 (fr) 1977-02-04
IL49971A0 (en) 1976-09-30
CH605889A5 (en:Method) 1978-10-13
SE7607856L (sv) 1977-01-09
AT355014B (de) 1980-02-11
US4241207A (en) 1980-12-23
AU506082B2 (en) 1979-12-13
ES449629A1 (es) 1977-07-01

Similar Documents

Publication Publication Date Title
JPS577743B2 (en:Method)
JPS5625360Y2 (en:Method)
FR2316939B1 (en:Method)
FR2341055B2 (en:Method)
JPS5418954U (en:Method)
JPS5437136B2 (en:Method)
JPS52107U (en:Method)
JPS5716854Y2 (en:Method)
JPS5316493Y2 (en:Method)
JPS51148187U (en:Method)
JPS5265337U (en:Method)
JPS5238585U (en:Method)
JPS51101445U (en:Method)
JPS51121869U (en:Method)
CH597884A5 (en:Method)
CH591705A5 (en:Method)
CH598519A5 (en:Method)
CH599075A5 (en:Method)
BG22932A1 (en:Method)
BG22979A1 (en:Method)
CH596048A5 (en:Method)
BG22683A1 (en:Method)
CH596063A5 (en:Method)
CH595778A5 (en:Method)
CH572709A5 (en:Method)